! The Capitol Complex is closed to the public due to COVID-19. All meetings will be held virtually online. View procedures and guidelines (PDF) for remote public comment and virtual meeting instructions (PDF).

Download Zipped Introduced WordPerfect HB0128.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 128

             1     

ELECTRONIC PRESCRIBING ACT

             2     
2009 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Ronda Rudd Menlove

             5     
Senate Sponsor: Peter C. Knudson

             6     
             7      LONG TITLE
             8      General Description:
             9          This bill enacts the Electronic Prescribing Act within Title 58, Occupations and
             10      Professions.
             11      Highlighted Provisions:
             12          This bill:
             13          .    defines terms;
             14          .    requires a practitioner to provide each existing patient of the practitioner with the
             15      option to participate in electronic prescribing;
             16          .    provides that a practitioner may not issue a prescription through electronic
             17      prescribing for a drug or device that the practitioner is prohibited by federal law or
             18      federal rule from issuing through electronic prescribing;
             19          .    requires a pharmacy to accept and comply with an electronic prescription that is
             20      transmitted in accordance with the requirements of this section and rules made by
             21      the Division of Occupational and Professional Licensing; and
             22          .    grants rulemaking authority to the Division of Occupational and Professional
             23      Licensing to:
             24              .    enforce the provisions of this bill;
             25              .    ensure that electronic prescribing is done in a secure manner;
             26              .    ensure that each patient is fully informed of the patient's rights, restrictions, and
             27      obligations pertaining to electronic prescribing; and


             28              .    grant a hardship exemption to a pharmacy, to the extent that the requirements of
             29      this bill would impose an extreme financial hardship on the pharmacy.
             30      Monies Appropriated in this Bill:
             31          None
             32      Other Special Clauses:
             33          None
             34      Utah Code Sections Affected:
             35      ENACTS:
             36          58-78-101, Utah Code Annotated 1953
             37          58-78-102, Utah Code Annotated 1953
             38          58-78-201, Utah Code Annotated 1953
             39     
             40      Be it enacted by the Legislature of the state of Utah:
             41          Section 1. Section 58-78-101 is enacted to read:
             42     
CHAPTER 78. ELECTRONIC PRESCRIBING ACT

             43     
Part 1. General Provisions

             44          58-78-101. Title.
             45          This chapter is known as the "Electronic Prescribing Act."
             46          Section 2. Section 58-78-102 is enacted to read:
             47          58-78-102. Definitions.
             48          As used in this chapter:
             49          (1) "Drug" is as defined in Section 58-37-2 .
             50          (2) "Electronic prescribing" means the electronic generation and transmission of a
             51      prescription between a practitioner and a pharmacy.
             52          (3) "Existing patient" means a person who a practitioner has:
             53          (a) obtained information regarding, in the usual course of professional practice, that is
             54      sufficient to:
             55          (i) establish a diagnoses;
             56          (ii) identify conditions; and
             57          (iii) identify contraindications to potential treatment; and
             58          (b) accepted as a patient.


             59          (4) (a) "Federal controlled substance" means a drug or substance included in Schedules
             60      I, II, III, IV, or V of the federal Controlled Substances Act, Title II, P.L. 91-513, or any federal
             61      controlled substance analog.
             62          (b) "Federal controlled substance" does not include:
             63          (i) distilled spirits, wine, or malt beverages, as those terms are defined or used in Title
             64      32A, Alcoholic Beverage Control Act, regarding tobacco or food;
             65          (ii) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             66      prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
             67      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
             68      transferred, or furnished as an over-the-counter medication without prescription; or
             69          (iii) dietary supplements, vitamins, minerals, herbs, or other similar substances
             70      including concentrates or extracts, which are not otherwise regulated by law, which may
             71      contain naturally occurring amounts of chemicals or substances listed in this chapter, or in rules
             72      adopted pursuant to Title 63G, Chapter 3, Utah Administrative Rulemaking Act.
             73          (5) (a) "Federal Controlled substance analog" means a substance the chemical structure
             74      of which is substantially similar to the chemical structure of a controlled substance listed in
             75      Schedules I and II of the federal Controlled Substances Act, Title II, P.L. 91-513:
             76          (i) which has a stimulant, depressant, or hallucinogenic effect on the central nervous
             77      system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central
             78      nervous system of controlled substances in the schedules set forth in Subsection (4); or
             79          (ii) which, with respect to a particular individual, is represented or intended to have a
             80      stimulant, depressant, or hallucinogenic effect on the central nervous system substantially
             81      similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of
             82      controlled substances in the schedules set forth in Subsection (4).
             83          (b) "Federal controlled substance analog" does not include:
             84          (i) a controlled substance currently scheduled in Schedules I through V of Section
             85      58-37-4 ;
             86          (ii) a substance for which there is an approved new drug application;
             87          (iii) a substance with respect to which an exemption is in effect for investigational use
             88      by a particular person under Section 505 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 355,
             89      to the extent the conduct with respect to the substance is permitted by the exemption;


             90          (iv) any substance to the extent not intended for human consumption before an
             91      exemption takes effect with respect to the substance;
             92          (v) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             93      prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
             94      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
             95      transferred, or furnished as an over-the-counter medication without prescription; or
             96          (vi) dietary supplements, vitamins, minerals, herbs, or other similar substances
             97      including concentrates or extracts, which are not otherwise regulated by law, which may
             98      contain naturally occurring amounts of chemicals or substances listed in this chapter, or in rules
             99      adopted pursuant to Title 63G, Chapter 3, Utah Administrative Rulemaking Act.
             100          (6) "Pharmacy" is as defined in Section 58-17b-102 .
             101          (7) "Practitioner" means an individual currently licensed, registered, or otherwise
             102      authorized by the state to prescribe and administer a drug in the course of professional practice.
             103          (8) "Prescription" is as defined in Section 58-37-2 .
             104          Section 3. Section 58-78-201 is enacted to read:
             105     
Part 2. Electronic Prescribing

             106          58-78-201. Electronic prescriptions -- Restrictions -- Rulemaking authority.
             107          (1) Subject to the provisions of this section, a practitioner shall provide each existing
             108      patient of the practitioner with the option of participating in electronic prescribing for
             109      prescriptions issued for the patient.
             110          (2) A practitioner may not issue a prescription through electronic prescribing for a
             111      drug, device, or federal controlled substance that the practitioner is prohibited by federal law or
             112      federal rule from issuing through electronic prescribing.
             113          (3) A pharmacy shall:
             114          (a) accept an electronic prescription that is transmitted in accordance with the
             115      requirements of this section and division rules; and
             116          (b) dispense a drug or device as directed in an electronic prescription described in
             117      Subsection (3)(a).
             118          (4) The division shall make rules to ensure that:
             119          (a) except as provided in Subsection (5), practitioners and pharmacies comply with this
             120      section;


             121          (b) electronic prescribing is conducted in a secure manner; and
             122          (c) each patient is fully informed of the patient's rights, restrictions, and obligations
             123      pertaining to electronic prescribing.
             124          (5) The division may, by rule, grant an exemption from the requirements of this section
             125      to a pharmacy to the extent that the pharmacy can establish, to the satisfaction of the division,
             126      that compliance with the requirements of this section would impose an extreme financial
             127      hardship on the pharmacy.




Legislative Review Note
    as of 1-26-09 1:06 PM


Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]